Growth through partnerships EpigenTek services a global customer base with distributors in more than thirty-six countries, presenting a sales opportunity to expand through new or deeper distributor agreements, regional channel programs, and co-marketing initiatives.

Epigenetic tooling A broad portfolio of proprietary epigenetics research products positions EpigenTek to upsell existing customers with complementary kits, assays, and library preparation tools aligned to DNA methylation and hydroxymethylation research, as well as next-generation sequencing workflows.

COVID era Past launches of SARS-CoV-2 assays and rapid serological tests indicate readiness to respond to infectious disease research needs; opportunities may exist to pursue analogous rapid testing or assay development collaborations for emerging pathogens.

Mid-market focus Revenue in the low tens of millions with a relatively small employee base signals agility; target mid-market academia and biotech firms seeking cost-effective, high-efficiency epigenetic solutions and quick deployment timelines.

Strategic collaborations Historical partnerships, such as with EpigenCare for consumer-facing epigenetic testing, suggest potential for new alliances in clinical research, personalized medicine, or dermatology/wellness verticals to broaden product applications and distribution.